Home › Karsinoma ng Nasopharynx › Missouri

Pag-aaral pangklinika para sa Karsinoma ng Nasopharynx sa Missouri

3 pag-aaral para sa Karsinoma ng Nasopharynx ang naghahanap ng mga kalahok sa mga site sa Missouri.

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Mercy Hospital South, St Louis
Mercy Hospital Saint Louis, St Louis

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06029270

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

Children's Mercy Hospitals and Clinics, Kansas City
Washington University School of Medicine, St Louis

Nagre-recruitPhase 2

Hanggang edad 21 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06064097

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Saint Francis Medical Center, Cape Girardeau
Lake Regional Hospital, Osage Beach

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06532279

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.